Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Last Chance to Screen
Study Number8470-451 G8
Age18 - 55
LocationDaytona Beach, Florida
Study DatesFeb. 01 - Jun. 21, 2022
This is a research study for an investigational drug being developed for the preventative treatment of migraine headaches.
The purpose of this study is to measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it, when given in two different formulations. In addition, the safety and tolerability of the study drugs will be evaluated.
• Healthy Non-Smoking Adults, ages 18-55
• BMI (body mass index) 18.5-30
• Trial involves 3 nights and 10 follow up visits
• Compensation up to $9,450 may be provided for time and participation
Call Now to Schedule Your Screening Appointment!
Check-In: Feb 1
Check-Out: Feb 4
Follow-up Visit: Feb 8
Follow-up Visit: Feb 15
Follow-up Visit: Feb 22
Follow-up Visit: Mar 1
Follow-up Visit: Mar 15
Follow-up Visit: Mar 29
Follow-up Visit: Apr 12
Follow-up Visit: Apr 26
Follow-up Visit: May 24
Follow-up Visit: Jun 21